Richard Gaynor - Net Worth and Insider Trading
Richard Gaynor Net Worth
The estimated net worth of Richard Gaynor is at least $2 Million dollars as of 2024-11-29. Richard Gaynor is the Director of Zai Lab Ltd and owns about 46,568 shares of Zai Lab Ltd (ZLAB) stock worth over $1 Million. Richard Gaynor is also the President of R&D of Neon Therapeutics Inc and owns about 156,500 shares of Neon Therapeutics Inc (NTGN) stock worth over $480,455. Details can be seen in Richard Gaynor's Latest Holdings Summary section.
Disclaimer: The insider information is derived from SEC filings. The estimated net worth is based on the final shares held after open market or private purchases and sales of common stock with a transaction code of "P" or "S" on Form 4, assuming that Richard Gaynor has not made any transactions after 2024-09-03 and currently still holds the listed stock(s). Please note that this estimate may not reflect the actual net worth.
Transaction Summary of Richard Gaynor
Richard Gaynor Insider Ownership Reports
Based on ownership reports from SEC filings, as the reporting owner, Richard Gaynor owns 4 companies in total, including Alkermes PLC (ALKS) , Neon Therapeutics Inc (NTGN) , and Infinity Pharmaceuticals Inc (INFIQ) among others .
Click here to see the complete history of Richard Gaynor’s form 4 insider trades.
Insider Ownership Summary of Richard Gaynor
| Ticker | Comapny | Transaction Date | Type of Owner |
|---|---|---|---|
| ALKS | Alkermes PLC | 2019-09-12 | director |
| NTGN | Neon Therapeutics Inc | 2020-05-06 | President of R&D |
| INFIQ | Infinity Pharmaceuticals Inc | 2020-03-16 | director |
 | | 2024-09-03 | director |
Richard Gaynor Latest Holdings Summary
Richard Gaynor currently owns a total of 2 stocks. Among these stocks, Richard Gaynor owns 46,568 shares of Zai Lab Ltd (ZLAB) as of September 3, 2024, with a value of $1 Million and a weighting of 73.17%. Richard Gaynor also owns 156,500 shares of Neon Therapeutics Inc (NTGN) as of November 27, 2019, with a value of $480,455 and a weighting of 26.83%.
Latest Holdings of Richard Gaynor
| Ticker | Comapny | Latest Transaction Date | Shares Owned | Current Price ($) | Current Value ($) |
|---|---|---|---|---|---|
| ZLAB | Zai Lab Ltd | 2024-09-03 | 46,568 | 28.13 | 1,309,958 |
| NTGN | Neon Therapeutics Inc | 2019-11-27 | 156,500 | 3.07 | 480,455 |
Holding Weightings of Richard Gaynor
Richard Gaynor Form 4 Trading Tracker
According to the SEC Form 4 filings, Richard Gaynor has made a total of 1 transactions in Zai Lab Ltd (ZLAB) over the past 5 years, including 0 buys and 1 sells. The most-recent trade in Zai Lab Ltd is the sale of 2,500 shares on September 3, 2024, which brought Richard Gaynor around $48,750.
According to the SEC Form 4 filings, Richard Gaynor has made a total of 0 transactions in Neon Therapeutics Inc (NTGN) over the past 5 years. The most-recent trade in Neon Therapeutics Inc is the sale of 65,322 shares on November 27, 2019, which brought Richard Gaynor around $85,572.
Insider Trading History of Richard Gaynor
- 1
Richard Gaynor Trading Performance
Richard Gaynor Ownership Network
Richard Gaynor Owned Company Details
What does Alkermes PLC do?
Who are the key executives at Alkermes PLC?
Richard Gaynor is the director of Alkermes PLC. Other key executives at Alkermes PLC include SVP & Chief Commercial Officer Christian Todd Nichols , SVP & Med Dev/Med Affairs & CMO Craig C. Hopkinson , and SVP & Corp Dev. & Alkermes & Inc. Michael J Landine .
Alkermes PLC (ALKS) Insider Trades Summary
Over the past 18 months, Richard Gaynor made no insider transaction in Alkermes PLC (ALKS). Other recent insider transactions involving Alkermes PLC (ALKS) include a net sale of 42,759 shares made by Christian Todd Nichols , a net sale of 8,128 shares made by Cato T Laurencin , and a net sale of 69,467 shares made by Craig C. Hopkinson .
In summary, during the past 3 months, insiders sold 74,675 shares of Alkermes PLC (ALKS) in total and bought 0 shares, with a net sale of 74,675 shares. During the past 18 months, 122,913 shares of Alkermes PLC (ALKS) were sold and 0 shares were bought by its insiders, resulting in a net sale of 122,913 shares.
Alkermes PLC (ALKS)'s detailed insider trading history can be found in Insider Trading Tracker table.
Alkermes PLC Insider Transactions
Richard Gaynor Mailing Address
Above is the net worth, insider trading, and ownership report for Richard Gaynor. You might contact Richard Gaynor via mailing address: C/o Neon Therapeutics, 40 Erie Street, Suite 110, Cambridge Ma 02139.
We'd love to learn more about your experiences on GuruFocus.com and how we can improve!
Take Survey
